findmyKOL
Clinical trialNCT04855526Not, yet, recruitingEarly phase 1Interventional

THC + CBD and Memory Study

SponsorHartford HospitalEnrollment9Cannabis IntoxicationCannabis UseMarijuana Use
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Alecia Dager, PhD

    Hartford Hospital - Olin Neuropsychiatry Research Center; Yale University

    Principal Investigator
  • Godfrey Pearlson, MD

    Hartford Hospital - Olin Neuropsychiatry Research Center; Yale University

    Principal Investigator
  • Michael Stevens, PhD

    Hartford Hospital - Olin Neuropsychiatry Research Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Dec 2025
Primary completion
30 Dec 2026
Completion
30 Dec 2026
Last update posted
17 Mar 2025
Registered enrollment
9
Registry id
NCT04855526

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.